Concord Biotech Standalone June 2024 Net Sales at Rs 215.80 crore, up 10.77% Y-o-Y
August 13, 2024 / 12:08 IST
Reported Standalone quarterly numbers for Concord Biotech are:Net Sales at Rs 215.80 crore in June 2024 up 10.77% from Rs. 194.83 crore in June 2023.
Quarterly Net Profit at Rs. 58.24 crore in June 2024 up 20.15% from Rs. 48.47 crore in June 2023.
EBITDA stands at Rs. 91.59 crore in June 2024 up 16.22% from Rs. 78.81 crore in June 2023.
Concord Biotech EPS has increased to Rs. 5.57 in June 2024 from Rs. 4.63 in June 2023.
| Concord Biotech shares closed at 1,510.55 on August 12, 2024 (NSE) and has given 5.18% returns over the last 6 months |
| Concord Biotech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 215.80 | 318.97 | 194.83 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 215.80 | 318.97 | 194.83 | | EXPENDITURE | | Consumption of Raw Materials | 55.03 | 55.67 | 39.48 | | Purchase of Traded Goods | 11.78 | 11.45 | 11.60 | | Increase/Decrease in Stocks | -18.51 | 21.73 | -10.67 | | Power & Fuel | -- | -- | -- | | Employees Cost | 31.66 | 33.96 | 28.25 | | Depreciation | 13.18 | 13.72 | 13.04 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 54.56 | 61.88 | 54.02 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 68.10 | 120.57 | 59.11 | | Other Income | 10.31 | 10.81 | 6.65 | | P/L Before Int., Excpt. Items & Tax | 78.41 | 131.38 | 65.77 | | Interest | 0.24 | 0.46 | 0.75 | | P/L Before Exceptional Items & Tax | 78.17 | 130.92 | 65.01 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 78.17 | 130.92 | 65.01 | | Tax | 19.93 | 33.70 | 16.54 | | P/L After Tax from Ordinary Activities | 58.24 | 97.21 | 48.47 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 58.24 | 97.21 | 48.47 | | Equity Share Capital | 10.46 | 10.46 | 10.46 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.57 | 9.29 | 4.63 | | Diluted EPS | 5.57 | 9.29 | 4.63 | | EPS After Extra Ordinary | | Basic EPS | 5.57 | 9.29 | 4.63 | | Diluted EPS | 5.57 | 9.29 | 4.63 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
